杏林製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/08/15 | 1,553 | 1,560 | 1,548 | 1,554 | -3 | -0.2% | 50,800 |
| 2025/08/14 | 1,557 | 1,566 | 1,556 | 1,557 | -9 | -0.6% | 47,000 |
| 2025/08/13 | 1,567 | 1,573 | 1,555 | 1,566 | -1 | -0.1% | 46,600 |
| 2025/08/12 | 1,565 | 1,576 | 1,552 | 1,567 | ±0 | ±0% | 93,000 |
| 2025/08/08 | 1,555 | 1,570 | 1,549 | 1,567 | +9 | +0.6% | 83,400 |
| 2025/08/07 | 1,575 | 1,575 | 1,553 | 1,558 | -11 | -0.7% | 55,600 |
| 2025/08/06 | 1,562 | 1,575 | 1,558 | 1,569 | +7 | +0.4% | 55,100 |
| 2025/08/05 | 1,558 | 1,580 | 1,557 | 1,562 | +3 | +0.2% | 103,600 |
| 2025/08/04 | 1,540 | 1,563 | 1,531 | 1,559 | +16 | +1% | 91,800 |
| 2025/08/01 | 1,546 | 1,558 | 1,532 | 1,543 | +20 | +1.3% | 149,000 |
| 2025/07/31 | 1,523 | 1,533 | 1,523 | 1,523 | ±0 | ±0% | 69,700 |
| 2025/07/30 | 1,517 | 1,532 | 1,517 | 1,523 | -2 | -0.1% | 89,100 |
| 2025/07/29 | 1,516 | 1,531 | 1,510 | 1,525 | -6 | -0.4% | 80,700 |
| 2025/07/28 | 1,524 | 1,534 | 1,519 | 1,531 | +7 | +0.5% | 47,700 |
| 2025/07/25 | 1,520 | 1,530 | 1,504 | 1,524 | +12 | +0.8% | 91,700 |
| 2025/07/24 | 1,508 | 1,514 | 1,503 | 1,512 | +9 | +0.6% | 67,500 |
| 2025/07/23 | 1,493 | 1,510 | 1,493 | 1,503 | +20 | +1.3% | 100,100 |
| 2025/07/22 | 1,488 | 1,493 | 1,481 | 1,483 | -10 | -0.7% | 50,400 |
| 2025/07/18 | 1,500 | 1,503 | 1,493 | 1,493 | -8 | -0.5% | 61,300 |
| 2025/07/17 | 1,488 | 1,501 | 1,488 | 1,501 | +3 | +0.2% | 47,300 |
| 2025/07/16 | 1,502 | 1,502 | 1,491 | 1,498 | -4 | -0.3% | 43,100 |
| 2025/07/15 | 1,500 | 1,510 | 1,493 | 1,502 | -1 | -0.1% | 43,800 |
| 2025/07/14 | 1,494 | 1,507 | 1,492 | 1,503 | +3 | +0.2% | 63,100 |
| 2025/07/11 | 1,489 | 1,502 | 1,483 | 1,500 | +14 | +0.9% | 77,600 |
| 2025/07/10 | 1,479 | 1,487 | 1,475 | 1,486 | +5 | +0.3% | 99,300 |
| 2025/07/09 | 1,470 | 1,492 | 1,470 | 1,481 | +13 | +0.9% | 51,800 |
| 2025/07/08 | 1,488 | 1,488 | 1,463 | 1,468 | -19 | -1.3% | 99,300 |
| 2025/07/07 | 1,490 | 1,496 | 1,482 | 1,487 | -3 | -0.2% | 125,400 |
| 2025/07/04 | 1,494 | 1,503 | 1,485 | 1,490 | +5 | +0.3% | 50,100 |
| 2025/07/03 | 1,484 | 1,491 | 1,475 | 1,485 | +4 | +0.3% | 67,100 |
| 2025/07/02 | 1,491 | 1,500 | 1,481 | 1,481 | -14 | -0.9% | 66,400 |
| 2025/07/01 | 1,517 | 1,521 | 1,494 | 1,495 | -21 | -1.4% | 80,800 |
| 2025/06/30 | 1,526 | 1,526 | 1,508 | 1,516 | -10 | -0.7% | 122,500 |
| 2025/06/27 | 1,500 | 1,526 | 1,498 | 1,526 | +18 | +1.2% | 301,000 |
| 2025/06/26 | 1,495 | 1,519 | 1,488 | 1,508 | +10 | +0.7% | 118,900 |
| 2025/06/25 | 1,531 | 1,531 | 1,472 | 1,498 | -19 | -1.3% | 235,900 |
| 2025/06/24 | 1,495 | 1,519 | 1,492 | 1,517 | +24 | +1.6% | 160,100 |
| 2025/06/23 | 1,458 | 1,496 | 1,456 | 1,493 | +28 | +1.9% | 136,700 |
| 2025/06/20 | 1,461 | 1,470 | 1,457 | 1,465 | -3 | -0.2% | 219,100 |
| 2025/06/19 | 1,482 | 1,487 | 1,462 | 1,468 | -14 | -0.9% | 53,600 |
| 2025/06/18 | 1,481 | 1,487 | 1,477 | 1,482 | +1 | +0.1% | 39,500 |
| 2025/06/17 | 1,484 | 1,491 | 1,475 | 1,481 | -3 | -0.2% | 66,300 |
| 2025/06/16 | 1,493 | 1,496 | 1,482 | 1,484 | +1 | +0.1% | 62,800 |
| 2025/06/13 | 1,498 | 1,498 | 1,476 | 1,483 | -19 | -1.3% | 137,900 |
| 2025/06/12 | 1,488 | 1,502 | 1,485 | 1,502 | +4 | +0.3% | 92,500 |
| 2025/06/11 | 1,493 | 1,512 | 1,493 | 1,498 | +13 | +0.9% | 98,200 |
| 2025/06/10 | 1,485 | 1,497 | 1,485 | 1,485 | -5 | -0.3% | 64,700 |
| 2025/06/09 | 1,502 | 1,503 | 1,482 | 1,490 | ±0 | ±0% | 56,500 |
| 2025/06/06 | 1,492 | 1,498 | 1,481 | 1,490 | -1 | -0.1% | 43,500 |
| 2025/06/05 | 1,490 | 1,496 | 1,483 | 1,491 | +1 | +0.1% | 57,000 |
1～
50
件表示中 / 3763件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 杏林製薬 | 155,400円 | -2.4% | -52.3% | 3.67% | 18.60倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| 持田薬 | 313,500円 | +5.1% | -7.0% | 2.55% | 20.58倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 202,100円 | +3.1% | -6.5% | 2.38% | 9.38倍 | 0.99倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 栄研化 | 235,500円 | +4.1% | -3.1% | 2.46% | 20.46倍 | 1.78倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 93,400円 | +20.3% | - | 0.00% | 165.60倍 | 1.28倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
市場注目の銘柄
チャート関連のコラム
